Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples